MedPath

Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis

Not Applicable
Recruiting
Conditions
Joint Infection
Septic Arthritis
Infection of Shoulder Joint
Infection of Hip Joint (Disorder)
Interventions
Diagnostic Test: Synovial Alpha-defensin assay
Diagnostic Test: Synovial Neutrophil elastase assay
Diagnostic Test: Synovial lactate assay
Diagnostic Test: Synovial C-reactive Protein (CRP)
Diagnostic Test: Synovial Staphylococcus spp antigen panel
Diagnostic Test: Synovial Candida spp antigen panel
Diagnostic Test: Synovial Enterococcus faecalis assay
Diagnostic Test: Synovial bacterial culture by BacT/Alert
Diagnostic Test: Synovial Cell count + differential (CBC)
Diagnostic Test: Synovial Gram Stain
Diagnostic Test: Synovial Leukocyte Esterase Test Strips
Diagnostic Test: Synovial PCR for Kingella kingae
Diagnostic Test: Serum Cell count + differential (CBC)
Diagnostic Test: Serum erythrocyte sedimentation rate (ESR)
Diagnostic Test: Serum C-reactive Protein (CRP)
Diagnostic Test: Serum D-dimer
Diagnostic Test: Serum Procalcitonin
Diagnostic Test: Blood Cultures
Diagnostic Test: Optional blood testing per standard of care (ASO, anti-strep, ANA, anti-DS-DNA, HLA-B27, RF, Lyme and other inflammatory/ rheumatologic markers )
Registration Number
NCT03704766
Lead Sponsor
Hospital for Special Surgery, New York
Brief Summary

Differentiating between septic arthritis and other causes of joint inflammation in pediatric patients is challenging and of the utmost importance because septic arthritis requires surgical debridement as part of the treatment regimen. The current gold standard to diagnose septic arthritis in children is a positive synovial fluid culture; however, joint cultures may take several days to return. If a bacterial infection is present, it requires immediate surgical intervention in order to prevent lasting articular cartilage damage. Frequently surgeons must decide whether to surgically debride a joint before culture results are available. There is no single lab test or clinical feature that reliably indicates bacterial infection over other causes of joint inflammation. The alpha-defensin assay has shown high sensitivity and specificity for joint infection in other studies.The purpose of this study is to determine the sensitivity and specificity of several synovial biomarkers for diagnosing pediatric septic arthritis.

Detailed Description

The purpose of this study is to determine if alpha-defensin and other proteins present in joint fluid may be able to rapidly diagnose bacterial joint infections. Patients with suspected joint infection typically undergo joint aspiration so that tests can be performed to help diagnose joint infection, including gram stain, cell count, and culture. Patients under 18 years old that are undergoing sampling of their joint fluid due to suspicion of infection or inflammation will be enrolled in this multi-center trial. Joint fluid will also be sampled from normative controls made up of patients who are undergoing an unrelated procedure without inflammation or infection. Joint fluid from patients with suspected inflammation/infection and from normative controls will be analysed for presence of alpha-defensin, leukocyte esterase, neutrophil elastase, synovial C-reactive protein, and synovial lactate. The alpha-defensin assay has shown high sensitivity and specificity for joint infection in other studies. Additionally a Staphylococcus spp antigen panel, Candida spp antigen panel, Enterococcus faecalis assay, BACTAlert culture, cell count plus differential, gram stain, and aerobic, anaerobic, and fungal cultures will be done using synovial fluid. A synovial fluid PCR for Kingella kingae will be performed if the patient is under eight years of age. Blood tests will include cell count and differential, erythrocyte sedimentation rate, C-reactive protein, procalcitonin, and D-dimer, as well as relevant inflammatory or rheumatologic marker tests. Results from these tests will be compared to joint fluid culture which the gold standard for diagnosing bacterial infection. The study includes 1 visit per patient, the standard of care visit in which the patient would be undergoing joint aspiration or arthroscopy. Once data has been collected, the sensitivity and specificity will be determined for these experimental tests both individually and in combination.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
442
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Normative ControlSerum D-dimerPatient undergoing procedure unrelated to infection/inflammation
Inflamed/Infected JointSynovial lactate assayPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSynovial Staphylococcus spp antigen panelPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSynovial Leukocyte Esterase Test StripsPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSynovial bacterial culture by BacT/AlertPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSynovial Cell count + differential (CBC)Patients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSynovial Gram StainPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSynovial Neutrophil elastase assayPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSynovial C-reactive Protein (CRP)Patients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSynovial Candida spp antigen panelPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Normative ControlSynovial Gram StainPatient undergoing procedure unrelated to infection/inflammation
Inflamed/Infected JointSynovial Alpha-defensin assayPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSynovial Enterococcus faecalis assayPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSerum D-dimerPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Normative ControlSynovial Neutrophil elastase assayPatient undergoing procedure unrelated to infection/inflammation
Normative ControlSynovial C-reactive Protein (CRP)Patient undergoing procedure unrelated to infection/inflammation
Normative ControlSynovial bacterial culture by BacT/AlertPatient undergoing procedure unrelated to infection/inflammation
Inflamed/Infected JointSerum erythrocyte sedimentation rate (ESR)Patients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointSerum ProcalcitoninPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Normative ControlSynovial Staphylococcus spp antigen panelPatient undergoing procedure unrelated to infection/inflammation
Normative ControlSynovial Enterococcus faecalis assayPatient undergoing procedure unrelated to infection/inflammation
Normative ControlSerum Cell count + differential (CBC)Patient undergoing procedure unrelated to infection/inflammation
Inflamed/Infected JointSynovial PCR for Kingella kingaePatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Normative ControlSynovial Alpha-defensin assayPatient undergoing procedure unrelated to infection/inflammation
Normative ControlSerum ProcalcitoninPatient undergoing procedure unrelated to infection/inflammation
Normative ControlBlood CulturesPatient undergoing procedure unrelated to infection/inflammation
Inflamed/Infected JointSerum C-reactive Protein (CRP)Patients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointBlood CulturesPatients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Normative ControlSynovial Leukocyte Esterase Test StripsPatient undergoing procedure unrelated to infection/inflammation
Normative ControlSynovial PCR for Kingella kingaePatient undergoing procedure unrelated to infection/inflammation
Normative ControlSerum erythrocyte sedimentation rate (ESR)Patient undergoing procedure unrelated to infection/inflammation
Normative ControlSerum C-reactive Protein (CRP)Patient undergoing procedure unrelated to infection/inflammation
Inflamed/Infected JointSerum Cell count + differential (CBC)Patients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Inflamed/Infected JointOptional blood testing per standard of care (ASO, anti-strep, ANA, anti-DS-DNA, HLA-B27, RF, Lyme and other inflammatory/ rheumatologic markers )Patients undergoing joint aspiration/debridement due to suspicion of septic joint or rheumatologic/inflammatory condition
Normative ControlSynovial lactate assayPatient undergoing procedure unrelated to infection/inflammation
Normative ControlSynovial Candida spp antigen panelPatient undergoing procedure unrelated to infection/inflammation
Normative ControlSynovial Cell count + differential (CBC)Patient undergoing procedure unrelated to infection/inflammation
Normative ControlOptional blood testing per standard of care (ASO, anti-strep, ANA, anti-DS-DNA, HLA-B27, RF, Lyme and other inflammatory/ rheumatologic markers )Patient undergoing procedure unrelated to infection/inflammation
Primary Outcome Measures
NameTimeMethod
Sensitivity and specificity of experimental testsInterim analysis at 2 years of study recruitment

Sensitivity and specificity have been selected as these are standard outcome tests when determining the utility of a diagnostic test.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Children's Healthcare of Atlanta

🇺🇸

Atlanta, Georgia, United States

Hospital for Special Surgery

🇺🇸

New York, New York, United States

Campbell Clinic

🇺🇸

Collierville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath